Pulmonary cavernous hemangiomatosis treated with interferon alfa-2a

  • J. M. Wu
  • , C. S. Lin
  • , J. N. Wang
  • , C. Y. Luo
  • , C. Y. Yu
  • , H. B. Yang

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)

Abstract

Pulmonary hemangiomatosis is a rare, usually fatal disorder characterized by diffuse proliferation of blood vessels within the thorax. We describe a 7-year-old boy with cavernous-type pulmonary hemangiomatosis successfully treated with interferon alfa-2a. He presented with respiratory distress and hemoptysis that were alleviated during a 2-year follow-up period.

Original languageEnglish
Pages (from-to)332-334
Number of pages3
JournalPediatric Cardiology
Volume17
Issue number5
DOIs
Publication statusPublished - 1996 Sept

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Pulmonary cavernous hemangiomatosis treated with interferon alfa-2a'. Together they form a unique fingerprint.

Cite this